Abstract
We are writing this letter in response to the article published by Aguilar et al. [1] where the authors highlighted the importance of early identification of group O platelet donors with critical anti-A/-B antibody titers in order to prevent passive transfusion of antibodies to non-O group recipients. In this study the authors identified that one out of two or three apheresis platelet donors of blood group O, had at least one critical titer of anti-A or anti-B IgM or IgG antibodies, that we thought was too high in number.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
